-
Bausch loses Salix president—and turnaround architect—to precision GI company
fiercepharma
September 08, 2019
After four years working to turn around Bausch Health's Salix Pharmaceuticals, President Mark McKenna is leaving.
-
Bristol-Myers Squibb announces post-closing leadership team
worldpharmanews
June 10, 2019
Bristol-Myers Squibb announces post-closing leadership team.
-
Boehringer Ingelheim announces finalists of the Making More Health Accelerator Program
worldpharmanews
May 15, 2019
Boehringer Ingelheim announces finalists of the Making More Health Accelerator Program.
-
Company diverts more than 9.2 million units of contact lens materials from waste stream
cphi-online
April 26, 2019
First-of-its-kind partnership recycles more than 55,200 pounds of contact lenses, blister packs and top foil in less than 3 years.
-
Aduro Biotech Appoints CMO
contractpharma
April 23, 2019
Nuyten brings expertise as a radiation oncologist specializing in cancer biology...
-
Bristol-Myers $74bn Celgene takeover gets shareholders approvals
pharmaceutical-technology
April 23, 2019
Bristol-Myers $74bn Celgene takeover gets shareholders approvals...
-
Pfizer and Lilly announce top-line results from long-term Phase 3 study of tanezumab in patients with osteoarthritis
worldpharmanews
April 23, 2019
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg.
-
Drug prices increased twice as fast during shortages
europeanpharmaceuticalreview
April 18, 2019
A team of researchers have found that drugs increase in price twice as fast during shortages than if there were not supply and demand imbalances…
-
Lilly, Dicerna Announce Global Licensing Agreement
contractpharma
October 30, 2018
Lilly, Dicerna Announce Global Licensing Agreement
-
Deals this week: Grifols, Cellesce, Arena Pharmaceuticals
pharmaceutical-technology
April 24, 2017
Spanish pharmaceutical company Grifols has raised €1bn ($1.06bn) through a public offering of bonds.
Due 1 May 2025, the unsecured bonds carry a coupon rate of 3.2%.